Exploring the Impact of Two-week Kava on the Metabolism of Nicotine and NNK
Status:
Withdrawn
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
Tobacco smoking is the leading cause of head and neck cancer in the United States. Smoking
cessation remains a challenge for many head/neck cancer survivors, indicating a need for
development of more effective smoking cessation interventions. Kava's properties as a proven
anxiolytic and carcinogen detoxifier warrant an investigation of its efficacy as an
innovative smoking cessation aid. Kava may also influence carcinogen (NNK specifically)
metabolism to help reduce carcinogenesis risk.